About this trial
This clinical trial evaluates the how well a virtually delivered solution-focused brief therapy (SFBT-C) works to decrease adolescent and young adult cancer survivors' psychological distress in comparison to enhanced treatment-as-usual care. Cancer and its treatment can have immediate and long-term impacts on adolescent and young adult cancer survivor's lives, including education and employment, financial stability, sexual health, and social, romantic, and family relationships. Consequently, many adolescent and young adult cancer survivors report psychological distress, often manifesting as depression and anxiety, and may benefit from psychotherapy to improve their engagement with medical treatment and overall quality of life. SFBT-C is a theory-driven and brief hope-based psychotherapy designed for the unique psychosocial needs facing adolescent and young adult cancer survivors. Undergoing SFBT-C may work better than treatment-as-usual care for the support of psychological distress in adolescent and young adult cancer survivors.
Eligibility criteria
Qualifiers
15 - 39 years old
Diagnosed with cancer
Receiving active cancer care (6 weeks post initial diagnosis to control for emotional responses to normative stressors) or within 5 years of post-treatment survivorship
Experiencing psychological distress (i.e., a t-score >= 57 on the Brief Symptom Inventory - 18 items [BSI-18])
Disqualifiers
End-of-life care
> 5 years into the post-treatment survivorship
Major physical challenges (e.g., hearing loss, developmental delay)
Acute mental health conditions (e.g., active psychosis, suicide risk)
Trial design
Treatments tested in this trial
- Behavioral Intervention
- Best Practice
- Communication Intervention
- Discussion
- Health Promotion and Education
- Health Promotion and Education
- Interview
- Questionnaire Administration
Treatment groups
Sponsors and collaborators
University of Michigan Rogel Cancer Center
Lead sponsor
Children's Cancer Research Fund
Collaborator